Society for Clinical Research Sites Welcomes Nimblify, Inc., as a New Global Impact Partner


Company News Release

Ellicott City, M.D. – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, announced a two-year relationship with Nimblify, Inc., developers of technologies that create industry-wide efficiencies in clinical research. Nimblify will participate as a Global Impact Partner (GIP) and align with 33 other sponsors, CROs, and service providers dedicated to promoting high-level communication and meaningful collaboration between industry stakeholders and clinical research sites globally.


“Nimblify’s commitment to become a GIP is indicative of their eagerness to strengthening site partnerships and accelerating collaboration amongst industry stakeholders. Collaboration with Nimblify is a significant strategic development for SCRS and we are pleased to welcome them to our community” commented Christine Pierre, SCRS President.


“I want to congratulate Christine and SCRS for bringing together a vibrant site community. We are quite excited to join as a Global Impact Partner,” said Shree Kalluri, Nimblify Founder & CEO. “We are particularly eager to partner with SCRS on the Site Score Card Initiative to bring Research Resonance Network to their sites, providing free comparative analytics and performance snapshots that can be shared with sponsors," added Kalluri. “Collaborating with research sites is core to who we are, so this partnership feels very natural to us. Together, with SCRS, we look forward to making great contributions in moving this industry forward.” 


As a Global Impact Partner (GIP), Nimblify will participate on the SCRS Global Impact Board at an executive level, and work closely with SCRS’ Leadership Council to determine strategic initiatives for SCRS.


About SCRS
SCRS is a global trade organization founded in 2012 which represents over 2,600 research sites in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Visit


About Nimblify

Nimblify, Inc. is a clinical trials technology company dedicated to creating industry-wide efficiencies by connecting stakeholders in clinical research. Nimblify created Participant Payments, a patient-centric payment system, and hosts Research Resonance Network, an award-winning benchmarking tool that uses a standard set of operational metrics and is free for sites. Nimblify also hosts the Protocol Calendar Exchange, a robust repository of pre-built, pre-reviewed protocol calendars available for clinical trial management systems. Spun out of Forte Research Systems in August 2015, Nimblify is a privately held company and is headquartered in Madison, Wis. For more information, please visit

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.